JP2014221758A5 - - Google Patents

Download PDF

Info

Publication number
JP2014221758A5
JP2014221758A5 JP2014109818A JP2014109818A JP2014221758A5 JP 2014221758 A5 JP2014221758 A5 JP 2014221758A5 JP 2014109818 A JP2014109818 A JP 2014109818A JP 2014109818 A JP2014109818 A JP 2014109818A JP 2014221758 A5 JP2014221758 A5 JP 2014221758A5
Authority
JP
Japan
Prior art keywords
antibody
mmp
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014109818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014221758A (ja
JP6105516B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014221758A publication Critical patent/JP2014221758A/ja
Publication of JP2014221758A5 publication Critical patent/JP2014221758A5/ja
Application granted granted Critical
Publication of JP6105516B2 publication Critical patent/JP6105516B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014109818A 2007-11-27 2014-05-28 関節炎の予防及び治療のための組成物及び方法 Active JP6105516B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US99052007P 2007-11-27 2007-11-27
US60/990,520 2007-11-27
US7712308P 2008-06-30 2008-06-30
US61/077,123 2008-06-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010534332A Division JP5615181B2 (ja) 2007-11-27 2008-11-26 関節炎の予防及び治療のための組成物及び方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017039151A Division JP2017149716A (ja) 2007-11-27 2017-03-02 関節炎の予防及び治療のための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2014221758A JP2014221758A (ja) 2014-11-27
JP2014221758A5 true JP2014221758A5 (enExample) 2015-04-23
JP6105516B2 JP6105516B2 (ja) 2017-03-29

Family

ID=40677991

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2010534331A Active JP5781764B2 (ja) 2007-11-27 2008-11-26 14−3−3η抗体、並びに関節炎の診断及び治療のためのその使用
JP2010534332A Active JP5615181B2 (ja) 2007-11-27 2008-11-26 関節炎の予防及び治療のための組成物及び方法
JP2014109818A Active JP6105516B2 (ja) 2007-11-27 2014-05-28 関節炎の予防及び治療のための組成物及び方法
JP2014236075A Active JP6054936B2 (ja) 2007-11-27 2014-11-21 14−3−3η抗体、並びに関節炎の診断及び治療のためのその使用
JP2017039151A Pending JP2017149716A (ja) 2007-11-27 2017-03-02 関節炎の予防及び治療のための組成物及び方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2010534331A Active JP5781764B2 (ja) 2007-11-27 2008-11-26 14−3−3η抗体、並びに関節炎の診断及び治療のためのその使用
JP2010534332A Active JP5615181B2 (ja) 2007-11-27 2008-11-26 関節炎の予防及び治療のための組成物及び方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014236075A Active JP6054936B2 (ja) 2007-11-27 2014-11-21 14−3−3η抗体、並びに関節炎の診断及び治療のためのその使用
JP2017039151A Pending JP2017149716A (ja) 2007-11-27 2017-03-02 関節炎の予防及び治療のための組成物及び方法

Country Status (11)

Country Link
US (6) US20110027269A1 (enExample)
EP (4) EP3192808A1 (enExample)
JP (5) JP5781764B2 (enExample)
KR (5) KR101945394B1 (enExample)
CN (3) CN101925364B (enExample)
AU (2) AU2008329466B2 (enExample)
BR (2) BRPI0819063A2 (enExample)
CA (2) CA2706479C (enExample)
HK (1) HK1253516A1 (enExample)
IL (3) IL205907A0 (enExample)
WO (2) WO2009067811A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2407975T3 (es) * 2006-05-09 2013-06-17 The University Of British Columbia Marcadores proteínicos de la artritis disueltos
BRPI0819063A2 (pt) 2007-11-27 2020-08-18 The University Of British Columbia método para tratamento de artrite, anticorpo, hibridoma, antagonista de 14-3-3, usos de um antagonista de 14-3-3, composições farmacêuticas, método para redução da expressão de mmp no sinóvio de um paciente e usos de uma composição farmacêutica
DK2406633T3 (en) 2009-03-11 2019-04-01 Augurex Life Sciences Corp COMPOSITIONS AND PROCEDURES FOR CHARACTERIZING ARTHRITIC CONDITIONS
US9474540B2 (en) 2009-10-08 2016-10-25 Ethicon-Endo-Surgery, Inc. Laparoscopic device with compound angulation
US8562592B2 (en) 2010-05-07 2013-10-22 Ethicon Endo-Surgery, Inc. Compound angle laparoscopic methods and devices
US9226760B2 (en) 2010-05-07 2016-01-05 Ethicon Endo-Surgery, Inc. Laparoscopic devices with flexible actuation mechanisms
GB201016494D0 (en) * 2010-09-30 2010-11-17 Queen Mary Innovation Ltd Polypeptide
WO2013056377A1 (en) * 2011-10-21 2013-04-25 Augurex Life Sciences Corporation Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
GB201200555D0 (en) * 2012-01-13 2012-02-29 Univ Birmingham Peptide
CN103060360A (zh) * 2013-01-04 2013-04-24 昆明理工大学 黑大豆14-3-3j蛋白基因的原核表达载体及其应用
CN104099348B (zh) * 2013-04-15 2017-03-29 上海市农业科学院 一种来源于耐高温菌的重金属结合蛋白基因及其抗重金属应用
CN103555750B (zh) * 2013-05-17 2015-04-08 温州医科大学附属第二医院 一种人子宫肌瘤14-3-3 γ高表达载体的构建方法及应用
US20160116652A1 (en) * 2013-06-20 2016-04-28 Merck Patent Gmbh Method for controlling the optical properties of uv filter layers
KR101489844B1 (ko) * 2013-06-27 2015-02-06 강원대학교산학협력단 14-3-3 시그마 유전자 결손 마우스, 이를 이용한 인 비보 패혈증 연구모델 개발 방법 및 그 응용
WO2015031645A1 (en) 2013-08-28 2015-03-05 Washington University Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv
US10583115B2 (en) 2014-10-08 2020-03-10 University Of South Australia Modulators of 14-3-3 functionality and uses thereof
KR101946884B1 (ko) * 2017-04-25 2019-02-13 고려대학교 산학협력단 대사체 분석을 이용한 베체트병의 진단방법
JP2019054181A (ja) * 2017-09-19 2019-04-04 東芝メモリ株式会社 半導体パッケージ
CN109596829A (zh) * 2017-12-07 2019-04-09 南京医科大学 一种肝癌标志蛋白及其检测方法
WO2019126737A1 (en) 2017-12-21 2019-06-27 Resolys Bio, Inc. Compositions and methods of treatment of ehlers-danlos syndromes
CN108344865A (zh) * 2018-01-05 2018-07-31 北京科美生物技术有限公司 检测14-3-3eta蛋白的均相免疫检测试剂盒及其应用
CN110579597A (zh) * 2018-05-23 2019-12-17 科美诊断技术股份有限公司 检测14-3-3 eta蛋白的非均相化学发光免疫检测试剂盒及其应用
CN110579600B (zh) * 2018-05-23 2023-12-26 科美诊断技术股份有限公司 通过生物标记物联检体外评估类风湿性关节炎是否存在的方法
CN110726843A (zh) * 2018-07-16 2020-01-24 科美诊断技术股份有限公司 检测14-3-3eta蛋白的化学发光免疫检测试剂盒及其应用
WO2020102623A1 (en) * 2018-11-15 2020-05-22 The University Of Toledo Materials and methods for the prevention of rheumatoid arthritis
MX2020014330A (es) 2018-12-26 2021-03-09 Caregen Co Ltd Composicion para relajacion muscular.
WO2020138674A1 (ko) * 2018-12-26 2020-07-02 (주)케어젠 근육 이완용 조성물
CN109593131B (zh) * 2018-12-27 2021-09-03 南京医科大学 一种抗14-3-3η蛋白单克隆抗体及其用途
CN109897109B (zh) * 2019-01-30 2022-09-09 常州市第二人民医院 抗肿瘤标志蛋白单克隆抗体及其用途
US11248325B2 (en) 2019-11-19 2022-02-15 Whirlpool Corporation Laundry appliance having a processing belt
CN111606977B (zh) * 2020-05-27 2021-11-09 福建农林大学 一种利用GF14f蛋白靶向多肽配体调控水稻弱势籽粒灌浆的方法
WO2022022524A1 (en) * 2020-07-27 2022-02-03 Huazhong University Of Science & Technology Prevention and/or treatment of a disease associated with stat3
CN117024557B (zh) * 2023-10-10 2024-01-30 天津外泌体科技有限公司 14-3-3蛋白theta异构体作为细胞外囊泡支架蛋白的应用和细胞外囊泡
CN117899196B (zh) * 2024-03-18 2024-06-04 中国人民解放军总医院第一医学中心 14-3-3zeta蛋白或YWHAZ基因在角膜损伤治疗中的应用

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526714A (en) 1982-12-13 1985-07-02 Cordis Europa N.V. Conjugates of anticoagulant and protein
US4956281A (en) 1987-06-03 1990-09-11 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3
GB8720833D0 (en) 1987-09-04 1987-10-14 Celltech Ltd Recombinant dna product
US6010902A (en) 1988-04-04 2000-01-04 Bristol-Meyers Squibb Company Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
WO1990005144A1 (en) 1988-11-11 1990-05-17 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US6291158B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertoire
US5747641A (en) 1989-12-21 1998-05-05 Biogen Inc Tat-derived transport polypeptide conjugates
US6596476B1 (en) 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
US5582996A (en) 1990-12-04 1996-12-10 The Wistar Institute Of Anatomy & Biology Bifunctional antibodies and method of preparing same
DE4118120A1 (de) 1991-06-03 1992-12-10 Behringwerke Ag Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
ES2227512T3 (es) 1991-12-02 2005-04-01 Medical Research Council Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
US5844094A (en) 1992-09-25 1998-12-01 Commonwealth Scientific And Industrial Research Organization Target binding polypeptide
ATE199392T1 (de) 1992-12-04 2001-03-15 Medical Res Council Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US5948765A (en) * 1996-03-15 1999-09-07 Washington University Inhibition of intracellular signal transduction by 14-3-3-binding peptides
US5998149A (en) 1996-04-05 1999-12-07 The United States Of America As Represented By The Department Of Health And Human Services Method of detecting transmissible spongiform encephalopathies
US5814507A (en) * 1996-05-24 1998-09-29 Genentech, Inc. κ/μ-like protein tyrosine phosphatase, PTP λ
WO1998026293A1 (en) 1996-12-12 1998-06-18 Neuromark Methods of detecting transmissible spongiform encephalopathies by detecting 14-3-3 protein isoforms
AU8296098A (en) 1997-07-08 1999-02-08 Board Of Regents, The University Of Texas System Compositions and methods for homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
DE19810721A1 (de) * 1998-03-12 1999-10-14 Werner Mueller Anwendung der 14-3-3 Proteine sowie Verfahren zur schnellen Bestimmung der 14-3-3 Proteine als sensitive Biomarker für Pollution u. a. mit polychlorierten Biphenylen (PCBs) und (Xeno)Östrogenen
NZ507063A (en) 1998-04-02 2003-11-28 Rigel Pharmaceuticals Inc Self-dimerising peptides causing the formation of compact structures
US7011952B2 (en) 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
US7105341B2 (en) 2000-03-06 2006-09-12 Rigel Pharmaceuticals. Inc. In vivo production of cyclic peptides
AU2001245838A1 (en) * 2000-03-17 2001-10-03 Gemini Science, Inc. Soluble mast cell function associated antigen (mafa) pharmaceutical compositionsand methods of making and using them
US20060062786A1 (en) 2000-11-08 2006-03-23 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to TRAIL receptors
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
KR100380147B1 (ko) 2001-01-18 2003-04-11 주식회사 엘지생명과학 류마티스성 자가면역 항체의 검출방법 및 검출키트
AU2002252011A1 (en) * 2001-02-21 2002-09-12 Emory University 14-3-3 binding molecules as sensitizers for anticancer therapies
DE10131912A1 (de) 2001-06-06 2002-12-19 Werner E G Mueller Verwendung von 14-3-3 Proteinen und Verfahren zu deren Bestimmung
US7171311B2 (en) 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
DE60237282D1 (de) 2001-06-28 2010-09-23 Domantis Ltd Doppelspezifischer ligand und dessen verwendung
US7172905B2 (en) 2001-08-07 2007-02-06 The University Of Chicago Polypeptide immobilization
DE10159414A1 (de) 2001-12-04 2003-06-18 Infineon Technologies Ag Bipolar-Transistor und Verfahren zum Herstellen desselben
EP1456410A2 (en) 2001-12-11 2004-09-15 AlgoNomics N.V. Method for displaying loops from immunoglobulin domains in different contexts
GB0208331D0 (en) * 2002-04-11 2002-05-22 Oxford Glycosciences Uk Ltd Proteins
EP2135879A3 (en) 2002-06-28 2010-06-23 Domantis Limited Ligand
NZ540196A (en) 2002-11-08 2008-09-26 Ablynx Nv Camelidae antibodies against imminoglobulin E and use thereof for the treatment of allergic disorders
CA2511910A1 (en) 2002-12-27 2004-07-15 Domantis Limited Dual specific single domain antibodies specific for a ligand and for the receptor of the ligand
US9028816B2 (en) 2003-01-10 2015-05-12 Ablynx N.V. Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
WO2005049806A2 (en) * 2003-03-14 2005-06-02 Nuvelo, Inc. Novel nucleic acids and polypeptides
US7101962B2 (en) * 2003-05-15 2006-09-05 Bristol-Myers Squibb Company Antibodies of the P2Y10 receptor useful in altering T lymphocyte function
DE102004026815A1 (de) 2003-06-03 2005-01-13 Kabushiki Kaisha Tokai Rika Denki Seisakusho Steuerung für ein Fernbedienungssystem
CA2533618A1 (en) 2003-06-25 2004-12-29 Queen's University At Kingston Methods for diagnosing, monitoring, staging and treating heart failure
JP4790624B2 (ja) * 2003-11-21 2011-10-12 ジョンズ ホプキンス ユニバーシティ 生体分子パーティションモチーフ及びそれらの使用
TWI281473B (en) 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
WO2005106038A2 (en) 2004-04-15 2005-11-10 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
US20070253961A1 (en) 2004-06-09 2007-11-01 Ulsan Industrial Education Foundation Pharmaceutical Composition Comprising the Anti-4-1Bb Antibody for Treating or Preventing Rheumatoid Arthritis
EP1844073A1 (en) 2005-01-31 2007-10-17 Ablynx N.V. Method for generating variable domain sequences of heavy chain antibodies
CA2600844A1 (en) 2005-03-14 2006-09-21 Medimmune, Inc. Macromolecules comprising a thioether cross-link
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
GB2428240A (en) 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
ES2407975T3 (es) * 2006-05-09 2013-06-17 The University Of British Columbia Marcadores proteínicos de la artritis disueltos
CA2694154A1 (en) 2007-10-03 2009-04-09 Osi Pharmaceuticals, Inc. Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
WO2009046267A1 (en) 2007-10-05 2009-04-09 University Of Virginia Patent Foundation Protein-based biomarkers for abdominal aortic aneurysm
US7919262B2 (en) 2007-11-07 2011-04-05 The Uab Research Foundation 14-3-3 proteins for diagnosis of Parkinson's disease
BRPI0819063A2 (pt) 2007-11-27 2020-08-18 The University Of British Columbia método para tratamento de artrite, anticorpo, hibridoma, antagonista de 14-3-3, usos de um antagonista de 14-3-3, composições farmacêuticas, método para redução da expressão de mmp no sinóvio de um paciente e usos de uma composição farmacêutica
WO2009097584A1 (en) 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
CN102171569A (zh) 2008-05-09 2011-08-31 杜克大学 检测和治疗癌症的自身抗体
WO2012006632A2 (en) 2010-07-09 2012-01-12 Somalogic, Inc. Lung cancer biomarkers and uses thereof
CN103429753A (zh) 2010-09-27 2013-12-04 私募蛋白质体公司 间皮瘤生物标记及其用途
US9209965B2 (en) 2014-01-14 2015-12-08 Microsemi Semiconductor Ulc Network interface with clock recovery module on line card

Similar Documents

Publication Publication Date Title
JP2014221758A5 (enExample)
TWI674274B (zh) 抗體-飛諾莫接合物
RU2720280C2 (ru) Антитело к notch4 человека
HRP20151227T1 (hr) Sastavi i postupci uporabe za terapeutska protutijela
BR112020015479A2 (pt) Anticorpos anticlaudina 18.2 e usos dos mesmos
JP2017113019A5 (enExample)
ES3009440T3 (en) Anti human annexin a1 antibody
JP2020536109A5 (enExample)
EP3266872A1 (en) Novel anti-pad4 antibody
CN102027015A (zh) 抗cxcr4抗体
RU2015136078A (ru) Антитело против с5 и способ предупреждения и лечения обусловленных комплементом заболеваний
HRP20150799T1 (hr) Sastavi i postupci za protutijela protiv komplementnog proteina c5
CN108289939B (zh) 抗人gpvi抗体及其用途
JP2017510567A5 (enExample)
ES2724364T3 (es) Procedimiento de tratamiento de fibrosis pulmonar idiopática
US20210032331A1 (en) Anti-lag 3 antibodies and uses thereof
AU2017205343A1 (en) Self-crosslinking antibodies
RU2017145662A (ru) Моноклональные антитела и способы их применения
TW201212938A (en) Antibodies that are capable of specifically binding tissue factor pathway inhibitor
TW201520226A (zh) 泛-elr+cxc趨化因子抗體
KR20150003278A (ko) 항-adamts-5 항체, 그의 유도체 및 용도
JP2018529661A5 (enExample)
KR20210108972A (ko) 항페리오스틴 항체 및 이의 용도
CN113350501A (zh) 用结合集落刺激因子1受体(csf1r)的抗体治疗病状的方法
TWI873313B (zh) 一種免疫細胞啟動劑的開發及應用